Last $1.19 USD
Change Today +0.055 / 4.87%
Volume 235.8K
HNSN On Other Exchanges
As of 3:48 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

hansen medical inc (HNSN) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/11/14 - $2.89
52 Week Low
05/12/14 - $1.10
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HANSEN MEDICAL INC (HNSN)

Related News

No related news articles were found.

hansen medical inc (HNSN) Related Businessweek News

No Related Businessweek News Found

hansen medical inc (HNSN) Details

Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies. The company offers Sensei Robotic Catheter Systems and Artisan Control Catheters for the manipulation, positioning, and control of mapping catheters during electrophysiology procedures; and Magellan Robotic System, a peripheral vascular interventional platform, which is used in combination with the Magellan Robotic Catheter for vessel navigation, catheter stability during the manual delivery and placement of therapeutic devices, reduced procedural radiation exposure and fatigue, and precise robotic control of distal catheter tips. The company also provides Lynx catheter, an irrigated ablation catheter; and CoHesion 3D Visualization Module, a software interface, which provides physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. It sells its products through direct sales force and distributors in the United States, European Union, and internationally. The company has agreements with St. Jude Medical, Inc. to integrate its Sensei system with St. Jude’s Ensite system, as well as to co-market the integrated product; and with Philips Medical Systems Nederland B.V. to co-develop integrated products. Hansen Medical, Inc. was founded in 2002 and is headquartered in Mountain View, California.

171 Employees
Last Reported Date: 03/13/14
Founded in 2002

hansen medical inc (HNSN) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $275.0K
Vice President of Marketing & Business Develo...
Total Annual Compensation: $241.5K
Senior Vice President of Global Sales
Total Annual Compensation: $230.0K
Compensation as of Fiscal Year 2013.

hansen medical inc (HNSN) Key Developments

Hansen Medical, Inc. Announces Management Changes

Hansen Medical, Inc. announced that on June 10, 2014, Board of Directors appointed Christopher P. Lowe, a member of Board of Directors, as interim Chief Financial Officer, and on such date Peter J. Mariani's role as Chief Financial Officer ended. Mr. Lowe will serve as interim Chief Financial Officer, and he has assumed the duties of principal financial and accounting officer. Mr. Lowe will continue to serve as a member of Board of Directors while he serves as interim Chief Financial Officer.

Hansen Medical, Inc. to Showcase its New Sensei(R) X2 Robotic System Prototype at Cardiostim Congress

Hansen Medical, Inc. will showcase its new Sensei(R) X2 Robotic System prototype at Cardiostim Congress from June 18 - 21 at the Acropolis Convention Center in Nice, France. The Sensei X2 features faster image processing and a slimmer design with the stability and reachability of its predecessor. The improved processing and imaging capabilities of the Sensei X2 will also be available to users of the current Sensei X upon release. The company anticipates commercialization of the Sensei X2 in the second half of the year. Through continued advancement of medical robotics, Hansen Medical has developed a next generation minimally-invasive, robotic catheter system, the Sensei X Robotic Catheter System which combines advanced levels of 3D catheter control and 3D visualization. This unique, technology has been used in over 10,000 patients, and is powered by a robotically controlled arm that allows for catheter navigation, stability and positioning within the patient's heart atria, allowing for the following system advantages: Catheter Stability with Force-Sensing, Instinctive 3D Control and Reduced Fluoro Time for Physician.

Hansen Medical Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

Hansen Medical reported unaudited consolidated earnings results for the first quarter of fiscal year 2014 ended March 31, 2014. Total revenue for the first quarter ended March 31, 2014 increased 25% to $3.7 million, compared to revenue of $3.0 million in the same period in 2013. Net loss for the first quarter of 2014 was $14.4 million or $0.14 per share, compared to a net loss of $17.2 million or $0.26 per share, in the first quarter of 2013. Net loss for the first quarter of 2014 included total non-cash stock compensation expense of $0.8 million compared to $1.1 million in the first quarter of 2013. Loss before income taxes was $14.4 million against $17.1 million of prior year period. Loss from operations was $13.2 million against $15.6 million of prior year period.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HNSN:US $1.19 USD +0.055

HNSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ABIOMED Inc $26.81 USD +0.51
AtriCure Inc $17.23 USD 0.00
LeMaitre Vascular Inc $8.01 USD +0.07
Stereotaxis Inc $3.39 USD +0.07
Spectranetics Corp/The $26.35 USD -0.45
View Industry Companies

Industry Analysis


Industry Average

Valuation HNSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.6x
Price/Book 7.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANSEN MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at